Cargando…
The impact of national centralized drug procurement on health expenditures for lung cancer inpatients: A difference-in-differences analysis in a large tertiary hospital in China
The availability and affordability of medicines remain major health challenges around the world. In March 2019, the Chinese government introduced a pilot National Centralized Drug Procurement (NCDP) program in order to reduce drug prices and improve the affordability of effective and safe medicines....
Autores principales: | Zhang, Yuan-jin, Ren, Yan, Zheng, Quan, Tan, Jing, Yao, Ming-hong, Huang, Yun-xiang, Zhang, Xia, Zou, Kang, Zhao, Shao-yang, Sun, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412196/ https://www.ncbi.nlm.nih.gov/pubmed/36033763 http://dx.doi.org/10.3389/fpubh.2022.956823 |
Ejemplares similares
-
Can the Profitability of Medical Enterprises Be Improved After Joining China's Centralized Drug Procurement? A Difference-in-Difference Design
por: Hua, Yu-Fei, et al.
Publicado: (2022) -
Impact of China’s National Centralized Drug Procurement Policy on pharmaceutical enterprises’ financial performance: a quasi-natural experimental study
por: Sun, Zhixuan, et al.
Publicado: (2023) -
A European arena for joint innovation in healthcare: The Platform for Innovation of Procurement and Procurement of Innovation (PiPPi)
por: Andrews, Margaret R., et al.
Publicado: (2023) -
Spatial and Temporal Differences in the Health Expenditure Efficiency of China: Reflections Based on the Background of the COVID-19 Pandemic
por: Shi, Yi, et al.
Publicado: (2022) -
Inpatient Treatment for the Middle-aged and Elderly in Central China
por: Jiang, Yan, et al.
Publicado: (2017)